The brain health devices market size has grown strongly in recent years. It will grow from $11.9 billion in 2025 to $12.79 billion in 2026 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to limited availability of advanced neuroimaging devices, growing prevalence of neurological disorders, increasing hospital and clinic infrastructure, reliance on conventional diagnostic procedures, awareness of cognitive health management.
The brain health devices market size is expected to see strong growth in the next few years. It will grow to $16.84 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to advancements in wearable brain health devices, integration with ai and machine learning algorithms, rising adoption of telehealth and remote monitoring, increasing government and private funding for neurotechnology, development of portable and cost-effective brain health solutions. Major trends in the forecast period include growing adoption of non-invasive brain monitoring devices, rising focus on early detection of neurological disorders, integration of wearable cognitive tracking devices, increasing demand for home-based brain health solutions, expansion of brain training and neurostimulation applications.
The increasing prevalence of neurological disorders is anticipated to support the expansion of the brain health devices market going forward. Neurological disorders are medical conditions that affect the nervous system, including the brain, spinal cord, and nerves, resulting in various cognitive, motor, and sensory impairments. The growing prevalence of neurological disorders is primarily influenced by an aging population and the rising incidence of chronic diseases such as diabetes and hypertension. In addition, environmental and lifestyle factors, along with advances in diagnostic technologies and genetic predispositions, contribute to the increasing number of reported cases. Brain health devices help monitor brain activity and deliver targeted therapies to manage symptoms, enhance cognitive performance, and improve patient outcomes. For example, in January 2025, according to the European Brain Council, a Belgium-based non-profit organization, approximately 7 million people in Europe were living with Alzheimer’s disease, with projections indicating this number could rise to nearly 14 million by 2030. As a result, the growing prevalence of neurological disorders is contributing significantly to the expansion of the brain health devices market.
Leading companies operating in the brain health monitoring market are focusing on developing innovative products, such as passive smartphone-based monitoring platforms, to continuously track cognitive and motor function changes without requiring active patient participation or wearable devices. Passive smartphone-based monitoring leverages routine keyboard interactions, motion data, and device usage patterns to unobtrusively generate clinically relevant neurological insights. For example, in May 2025, Neurocast, a Netherlands-based provider of digital health and brain health monitoring solutions, launched its FDA-registered Neurocast platform in the US. The platform analyzes everyday smartphone interactions, including keystrokes, motion patterns, and usage behaviors, to identify subtle neurological changes, enabling early detection of cognitive or motor decline in patients with conditions such as multiple sclerosis, Alzheimer’s disease, ADHD, and depression. Key features of the Neurocast platform include continuous data collection through routine phone use, a privacy-focused design requiring no active input or wearables, GDPR compliance, ISO 27001 certification, and real-world clinical validation across European studies involving hundreds of patients. This launch enables US healthcare providers to access scalable, unobtrusive, and data-driven insights for proactive brain health management, representing a significant milestone in remote neurological care.
In March 2024, Linus Health Inc., a US-based software company, acquired Aural Analytics Inc. for an undisclosed amount. This acquisition enhances Linus Health’s cognitive assessment platform by incorporating advanced speech analytics to enable more accurate identification of cognitive impairments. The integration expands the tools available to clinicians and researchers while increasing Linus Health’s presence within the life sciences sector. Aural Analytics Inc. is a US-based healthcare company specializing in brain health analytics solutions.
Major companies operating in the brain health devices market are Johnson & Johnson Services Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, electroCore Inc., Masimo Corporation, Integra LifeSciences Corporation, LivaNova plc, Natus Medical Incorporated, Cadwell Industries Inc., NeuroSky Inc., Neuropace Inc., Compumedics Limited, Magstim Co. Ltd., Mindmaze SA, Brain Products GmbH, Emotiv Inc., Electrical Geodesics Inc., BrainScope Company Inc., Soterix Medical Inc., Advanced Brain Monitoring Inc., Bio-Signal Group Corp., Cognionics Inc.
North America was the largest region in the brain health devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain health devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brain health devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the brain health devices market by increasing the cost of imported neuroimaging equipment, wearable headsets, and neurostimulation devices. Segments such as fMRI systems, MEG devices, and portable EEG units are most impacted, with regions like Asia-Pacific and Europe facing higher import duties. This has resulted in higher procurement costs and supply chain adjustments. Positively, tariffs have encouraged local manufacturing, innovation in device miniaturization, and increased domestic investment in brain health technologies.
The brain health devices market research report is one of a series of new reports that provides brain health devices market statistics, including brain health devices industry global market size, regional shares, competitors with a brain health devices market share, detailed brain health devices market segments, market trends and opportunities, and any further data you may need to thrive in the brain health devices industry. This brain health devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Brain health devices are technologies designed to monitor, evaluate, or support brain activity, cognitive performance, and mental wellness. They may include wearable brainwave monitors and neurostimulation systems that help manage conditions such as depression or epilepsy, assist in early detection of neurological disorders, and support cognitive improvement through training and biofeedback.
The primary device categories in the brain health devices market include magnetic resonance imaging, magnetoencephalogram, computed tomography, transcranial Doppler devices, and others. Magnetic resonance imaging (MRI) is a non-invasive imaging method that uses magnetic fields and radio waves to generate detailed images of the brain’s anatomy. The procedures include both invasive and non-invasive approaches, with applications covering sleep disorders, accidental injuries, Alzheimer’s disease, epilepsy, stroke, and others. The end users include hospitals and clinics, diagnostic imaging centers, homecare environments, assisted living facilities, and others.
The brain health devices market consists of sales of electroencephalography (EEG) headsets, neurostimulation devices, brain training software, cognitive assessment tools, and wearable biosensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The brain health devices market size is expected to see strong growth in the next few years. It will grow to $16.84 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to advancements in wearable brain health devices, integration with ai and machine learning algorithms, rising adoption of telehealth and remote monitoring, increasing government and private funding for neurotechnology, development of portable and cost-effective brain health solutions. Major trends in the forecast period include growing adoption of non-invasive brain monitoring devices, rising focus on early detection of neurological disorders, integration of wearable cognitive tracking devices, increasing demand for home-based brain health solutions, expansion of brain training and neurostimulation applications.
The increasing prevalence of neurological disorders is anticipated to support the expansion of the brain health devices market going forward. Neurological disorders are medical conditions that affect the nervous system, including the brain, spinal cord, and nerves, resulting in various cognitive, motor, and sensory impairments. The growing prevalence of neurological disorders is primarily influenced by an aging population and the rising incidence of chronic diseases such as diabetes and hypertension. In addition, environmental and lifestyle factors, along with advances in diagnostic technologies and genetic predispositions, contribute to the increasing number of reported cases. Brain health devices help monitor brain activity and deliver targeted therapies to manage symptoms, enhance cognitive performance, and improve patient outcomes. For example, in January 2025, according to the European Brain Council, a Belgium-based non-profit organization, approximately 7 million people in Europe were living with Alzheimer’s disease, with projections indicating this number could rise to nearly 14 million by 2030. As a result, the growing prevalence of neurological disorders is contributing significantly to the expansion of the brain health devices market.
Leading companies operating in the brain health monitoring market are focusing on developing innovative products, such as passive smartphone-based monitoring platforms, to continuously track cognitive and motor function changes without requiring active patient participation or wearable devices. Passive smartphone-based monitoring leverages routine keyboard interactions, motion data, and device usage patterns to unobtrusively generate clinically relevant neurological insights. For example, in May 2025, Neurocast, a Netherlands-based provider of digital health and brain health monitoring solutions, launched its FDA-registered Neurocast platform in the US. The platform analyzes everyday smartphone interactions, including keystrokes, motion patterns, and usage behaviors, to identify subtle neurological changes, enabling early detection of cognitive or motor decline in patients with conditions such as multiple sclerosis, Alzheimer’s disease, ADHD, and depression. Key features of the Neurocast platform include continuous data collection through routine phone use, a privacy-focused design requiring no active input or wearables, GDPR compliance, ISO 27001 certification, and real-world clinical validation across European studies involving hundreds of patients. This launch enables US healthcare providers to access scalable, unobtrusive, and data-driven insights for proactive brain health management, representing a significant milestone in remote neurological care.
In March 2024, Linus Health Inc., a US-based software company, acquired Aural Analytics Inc. for an undisclosed amount. This acquisition enhances Linus Health’s cognitive assessment platform by incorporating advanced speech analytics to enable more accurate identification of cognitive impairments. The integration expands the tools available to clinicians and researchers while increasing Linus Health’s presence within the life sciences sector. Aural Analytics Inc. is a US-based healthcare company specializing in brain health analytics solutions.
Major companies operating in the brain health devices market are Johnson & Johnson Services Inc., Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, electroCore Inc., Masimo Corporation, Integra LifeSciences Corporation, LivaNova plc, Natus Medical Incorporated, Cadwell Industries Inc., NeuroSky Inc., Neuropace Inc., Compumedics Limited, Magstim Co. Ltd., Mindmaze SA, Brain Products GmbH, Emotiv Inc., Electrical Geodesics Inc., BrainScope Company Inc., Soterix Medical Inc., Advanced Brain Monitoring Inc., Bio-Signal Group Corp., Cognionics Inc.
North America was the largest region in the brain health devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain health devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brain health devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the brain health devices market by increasing the cost of imported neuroimaging equipment, wearable headsets, and neurostimulation devices. Segments such as fMRI systems, MEG devices, and portable EEG units are most impacted, with regions like Asia-Pacific and Europe facing higher import duties. This has resulted in higher procurement costs and supply chain adjustments. Positively, tariffs have encouraged local manufacturing, innovation in device miniaturization, and increased domestic investment in brain health technologies.
The brain health devices market research report is one of a series of new reports that provides brain health devices market statistics, including brain health devices industry global market size, regional shares, competitors with a brain health devices market share, detailed brain health devices market segments, market trends and opportunities, and any further data you may need to thrive in the brain health devices industry. This brain health devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Brain health devices are technologies designed to monitor, evaluate, or support brain activity, cognitive performance, and mental wellness. They may include wearable brainwave monitors and neurostimulation systems that help manage conditions such as depression or epilepsy, assist in early detection of neurological disorders, and support cognitive improvement through training and biofeedback.
The primary device categories in the brain health devices market include magnetic resonance imaging, magnetoencephalogram, computed tomography, transcranial Doppler devices, and others. Magnetic resonance imaging (MRI) is a non-invasive imaging method that uses magnetic fields and radio waves to generate detailed images of the brain’s anatomy. The procedures include both invasive and non-invasive approaches, with applications covering sleep disorders, accidental injuries, Alzheimer’s disease, epilepsy, stroke, and others. The end users include hospitals and clinics, diagnostic imaging centers, homecare environments, assisted living facilities, and others.
The brain health devices market consists of sales of electroencephalography (EEG) headsets, neurostimulation devices, brain training software, cognitive assessment tools, and wearable biosensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Brain Health Devices Market Characteristics
3. Brain Health Devices Market Supply Chain Analysis
4. Global Brain Health Devices Market Trends and Strategies
5. Brain Health Devices Market Analysis of End Use Industries
7. Global Brain Health Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Brain Health Devices Total Addressable Market (TAM) Analysis for the Market
9. Brain Health Devices Market Segmentation
10. Brain Health Devices Market Regional and Country Analysis
11. Asia-Pacific Brain Health Devices Market
12. China Brain Health Devices Market
13. India Brain Health Devices Market
14. Japan Brain Health Devices Market
15. Australia Brain Health Devices Market
16. Indonesia Brain Health Devices Market
17. South Korea Brain Health Devices Market
18. Taiwan Brain Health Devices Market
19. South East Asia Brain Health Devices Market
20. Western Europe Brain Health Devices Market
21. UK Brain Health Devices Market
22. Germany Brain Health Devices Market
23. France Brain Health Devices Market
24. Italy Brain Health Devices Market
25. Spain Brain Health Devices Market
26. Eastern Europe Brain Health Devices Market
27. Russia Brain Health Devices Market
28. North America Brain Health Devices Market
29. USA Brain Health Devices Market
30. Canada Brain Health Devices Market
31. South America Brain Health Devices Market
32. Brazil Brain Health Devices Market
33. Middle East Brain Health Devices Market
34. Africa Brain Health Devices Market
36. Brain Health Devices Market Competitive Landscape and Company Profiles
37. Brain Health Devices Market Other Major and Innovative Companies
40. Brain Health Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Brain Health Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses brain health devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for brain health devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The brain health devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Magnetic Resonance Imaging; Magneto Encephalogram; Computed Tomography; Transcranial Doppler Device; Other Device Types2) By Procedure: Invasive; Non-Invasive
3) By Application: Sleep Disorders; Accidental Injuries; Alzheimer's Disease; Epilepsy; Stroke; Other Applications
4) By End-User: Hospitals And Clinics; Diagnostic Imaging Centers; Homecare Settings; Assisted Living Facilities; Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Functional MRI (fMRI); Diffusion Tensor Imaging (DTI); MRI Spectroscopy2) By Magnetoencephalogram (MEG): Whole-Head MEG Systems; Cooled MEG Systems
3) By Computed Tomography (CT): Standard CT Scanners; CT Angiography; High-Resolution CT Scanners
4) By Transcranial Doppler Device: Handheld Transcranial Doppler Devices; Portable Transcranial Doppler Devices
5) By Other Device Types: Electroencephalogram (EEG) Devices; Positron Emission Tomography (PET) Scanners; Near-Infrared Spectroscopy (NIRS) Devices
Companies Mentioned: Johnson & Johnson Services Inc.; Medtronic plc; Siemens Healthineers AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Boston Scientific Corporation; electroCore Inc.; Masimo Corporation; Integra LifeSciences Corporation; LivaNova plc; Natus Medical Incorporated; Cadwell Industries Inc.; NeuroSky Inc.; Neuropace Inc.; Compumedics Limited; Magstim Co. Ltd.; Mindmaze SA; Brain Products GmbH; Emotiv Inc.; Electrical Geodesics Inc.; BrainScope Company Inc.; Soterix Medical Inc.; Advanced Brain Monitoring Inc.; Bio-Signal Group Corp.; Cognionics Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Brain Health Devices market report include:- Johnson & Johnson Services Inc.
- Medtronic plc
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- GE HealthCare Technologies Inc.
- Boston Scientific Corporation
- electroCore Inc.
- Masimo Corporation
- Integra LifeSciences Corporation
- LivaNova plc
- Natus Medical Incorporated
- Cadwell Industries Inc.
- NeuroSky Inc.
- Neuropace Inc.
- Compumedics Limited
- Magstim Co. Ltd.
- Mindmaze SA
- Brain Products GmbH
- Emotiv Inc.
- Electrical Geodesics Inc.
- BrainScope Company Inc.
- Soterix Medical Inc.
- Advanced Brain Monitoring Inc.
- Bio-Signal Group Corp.
- Cognionics Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.79 Billion |
| Forecasted Market Value ( USD | $ 16.84 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
